AAP
Ardsley Advisory Partners’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q4 | – | Sell |
-565,000
| Closed | -$7.32M | – | 172 |
|
|
2014
Q3 | $7.32M | Buy |
565,000
+70,000
| +14% | +$907K | 0.97% | 28 |
|
|
2014
Q2 | $8.08M | Buy |
495,000
+85,500
| +21% | +$1.4M | 1.03% | 30 |
|
|
2014
Q1 | $7.24M | Buy |
409,500
+52,500
| +15% | +$928K | 1.08% | 29 |
|
|
2013
Q4 | $8.64M | Buy |
357,000
+92,000
| +35% | +$2.23M | 1.15% | 21 |
|
|
2013
Q3 | $9.39M | Sell |
265,000
-145,000
| -35% | -$5.14M | 1.92% | 16 |
|
|
2013
Q2 | $6.4M | Buy |
+410,000
| New | +$6.4M | 1.4% | 24 |
|